Pfizer is working to get approval on a new vaccine that could protect people against Lyme disease.
Doctors break down what you need to know about the four-dose vaccine.
The annual tick report shows Lone Star ticks have established populations along Connecticut's shoreline, raising the risk of ...
An experimental vaccine from Pfizer and Valneva reduced the risk of developing Lyme disease by more than 70%, according to ...
CAPC’s 2026 forecast shows Lyme disease, heartworm, ehrlichiosis and anaplasmosis expanding nationwide, urging year-round ...
The war in the Middle East so far has not appreciably disrupted pharmaceutical supply chains, but the conflict could do so as ...
The Companion Animal Parasite Council (CAPC) – the leading authority on vector-borne diseases affecting pets and people – ...
An experimental six-strain Lyme vaccine has demonstrated more than 70% efficacy in preventing Lyme disease in people aged ...
In this week’s edition of InnovationRx, we look at a serial entrepreneur’s effort to build an FDA-approved AI doctor, ...
Experimental shot shows reduced infections but fewer cases in study make efficacy harder to assess ahead of planned regulatory submission.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results